Trials / Terminated
TerminatedNCT00512980
PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma
A Randomized Phase II Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Patients With Intermediate Stage Hodgkin's Lymphoma
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University of Cologne · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
A randomized phase II study of prednisone, vinblastine, doxorubicin, and gemcitabine in patients with intermediate stage Hodgkin's lymphoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prednisone | |
| DRUG | vinblastine | |
| DRUG | doxorubicin | |
| DRUG | gemcitabine |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2013-11-01
- First posted
- 2007-08-08
- Last updated
- 2015-12-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00512980. Inclusion in this directory is not an endorsement.